Home › Prostate Cancer › Pennsylvania › York
Prostate Cancer clinical trials in York, PA
5 studies for Prostate Cancer are looking for participants at sites in and around York (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- WellSpan York Cancer Center, York
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecruitingPhase 3
- WellSpan Health-York Cancer Center, York
- WellSpan Health-York Hospital, York
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecruitingPhase 3
- UPMC Memorial, York
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingPhase 3
- WellSpan Health-York Cancer Center, York
Customized TULSA-PRO Ablation Registry
RecruitingObservational study
- Wellspan Health, York
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN42 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Other studies in York
- Non-Small Cell Lung Cancer15 studies
- Lung Cancer8 studies
- Cancer (all types)8 studies
- Breast Cancer8 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Ovarian Cancer6 studies
- Coronary Artery Disease5 studies
- Colorectal Cancer4 studies
- Endometrial Cancer4 studies
- Triple-Negative Breast Cancer4 studies
- Esophageal Cancer4 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.